Zimbabwe has declined a major American health deal worth 367 million US dollars (£272m) over five years due to Washington's insistence on sensitive information.
This rejection was revealed following a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "unbalanced".
An official spokesperson later clarified that the United States was demanding access to health data for research and profit but refused to guarantee the benefits from any future vaccines.
"We must now begin the challenging and unfortunate process of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for more dialogue to find a deal acceptable to all parties so the nation's vital HIV programme can continue.
Broader Background
Zimbabwe's decision follows a similar situation in Kenya, where a high court halted a related health funding agreement following concerns were raised about the safety of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its spending was "wasteful" and his government was seeking government-to-government deals to boost transparency and responsibility.
As per reports, Sixteen African countries have so far agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to provide its biological resources and data over an extended period, with no equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.
"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the final treatments would be available to our population if a new health crisis arise."
National Interest and Global Health
Mangwana further said that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting systems already established via the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.
"This mechanism is designed to ensure that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
These objections over the US deal "are not meant as opposition to America," he added.
"We welcome continued discussions with our US partners on how subsequent co-operation could be arranged in a way that respects the independence and dignity of both nations."
Medical Community Reaction
Medical experts said it understood the government's concerns, but urged that negotiations must proceed considering a large portion of the nation's HIV programmes depended on international support.
"Where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.
This impasse emphasises the continuing tensions between receiving vital foreign assistance and safeguarding local interests in an increasingly data-driven world.